Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)
-NSE 969.35 
8.10(0.84%) 17:59 SGT
| Prev Close: | 961.25 |
|---|
| Open: | 951.00 |
|---|
| Bid: | 969.35 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 943.00 - 984.90 |
|---|
| 52wk Range: | 580.00 - 1,084.80 |
|---|
| Volume: | 1,558,342 |
|---|
| Avg Vol (3m): | 1,012,130 |
|---|
| Market Cap: | 1.00T |
|---|
| P/E (ttm): | 33.43 |
|---|
| EPS (ttm): | 29.00 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in INR.
Headlines
- Sensex falls for third day; ignore Fitch upgrade, finmin pledgeReuters(Thu, 13 Jun)
- Sun Pharma slumps after $550 mln patent suit settlement with PfizerReuters(Thu, 13 Jun)
- Teva, Sun Pharma to pay $2.15 billion to settle Pfizer patent suitReuters(Thu, 13 Jun)
- Teva, Sun Pharma to pay $2.15 billion to settle Pfizer patent suitReuters(Wed, 12 Jun)
- Severn Trent deal blow hits "merger arb" fundsReuters(Wed, 12 Jun)
- Sensex falls 100 points; FII selling, rupee weakness weighsReuters(Thu, 6 Jun)
- Sensex snaps losing streak; foreign flows a worryReuters(Wed, 5 Jun)
- Sun Pharma gains; Meda says no takeover talksReuters(Wed, 5 Jun)
- Swedish drugmaker Meda says not in sale talksReuters(Wed, 5 Jun)
- Sensex falls; ITC, RIL, ICICI dragReuters(Mon, 3 Jun)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 8.83 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Sun Pharmaceutical Industries Limited, a specialty pharma company, manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally.
View More